(Q26827191)

H. M. van den Berg

2

1 reference

J. Oldenburg

3

1 reference

J. Astermark

4

1 reference

P. G. de Groot

5

1 reference

A. R. Thompson

7

1 reference

W. van Heerde

8

1 reference

J. Boekhorst

9

1 reference

C. H. Miller

10

1 reference

S. le Cessie

11

1 reference

J. G. van der Bom

12

1 reference

language of work or name

1 reference

22 March 2012

1 reference

1 reference

119

1 reference

PubMed

issue

12

1 reference

PubMed

page(s)

2922-34

1 reference

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Computation of exact confidence intervals for the odds ratio

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Evidence for a third transcript from the human factor VIII gene

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Lithuanian haemophilia A and B registry comprising phenotypic and genotypic data

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Some factor VIII exon 14 frameshift mutations cause moderately severe haemophilia A.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

The genetic basis of inhibitor development in haemophilia A.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

The epidemiology of inhibitors in haemophilia A: a systematic review

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Analysis of the consequences of premature termination codons within factor VIII coding sequences.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Inhibitor development in previously untreated patients with hemophilia A: a prospective long-term follow-up comparing plasma-derived and recombinant products

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

The molecular basis of hemophilia A: genotype-phenotype relationships and inhibitor development

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Inhibitors of factor VIII in black patients with hemophilia

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

The factor VIII Structure and Mutation Resource Site: HAMSTeRS version 4

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Molecular genotyping of hemophilia A in Saudi Arabia: report of 2 novel mutations

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Haemophilia A mutations in the UK: results of screening one-third of the population.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Factor VIII gene intron 1 inversion: lower than expected prevalence in Italian haemophiliac severe patients

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Mutation analysis in 51 patients with haemophilia A: report of 10 novel mutations and correlations between genotype and clinical phenotype

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Identification of factor VIII gene mutations in 101 patients with haemophilia A: mutation analysis by inversion screening and multiplex PCR and CSGE and molecular modelling of 10 novel missense substitutions

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Genetic diagnosis of haemophilia and other inherited bleeding disorders.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Spectrum of mutations in Albanian patients with haemophilia A: identification of ten novel mutations in the factor VIII gene

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

The spectrum of the factor 8 (F8) defects in Taiwanese patients with haemophilia A.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from Southern Italy.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Factor VIII mutations in 42 Moldovan haemophilia A families, including 12 that are novel

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Study of mutations in Jordanian patients with haemophilia A: identification of five novel mutations

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Incidence of inhibitors in a cohort of 838 males with hemophilia A previously treated with factor VIII concentrates

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Factor VIII gene mutations profile in 148 Chinese hemophilia A subjects

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Spectrum of causative mutations in patients with haemophilia A in Austria

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Social participation of patients with hemophilia in the Netherlands.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Sixteen novel hemophilia A causative mutations in the first Argentinian series of severe molecular defects

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

Severe and moderate hemophilia A: identification of 38 new genetic alterations

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021

The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2011-09-379453

7 January 2021